GlassScriptPhysician profile
Alison Baumann
NPI 1902290778
$1,809.27
in general payments reported to CMS, 2019-2025
21 companies · $15.79 in 2025
The $15.79 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $450 · 2023: $701 · 2024: $104 · 2025: $15.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Entertainment: $17.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.65 |
| Entertainment | $17.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $313.93 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $197.31 | 2021 | |
| Abbvie INC. | $192.02 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $184.15 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $162.07 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $116.40 | 2021-2023 | Breztri |
| Paratek Pharmaceuticals, INC. | $112.71 | 2022 | |
| Sage Therapeutics, LLC | $106.43 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $102.41 | 2022 | |
| Gilead Sciences, INC. | $96.53 | 2023 | |
| Esperion Therapeutics, INC. | $42.79 | 2021 | |
| Amgen INC. | $23.36 | 2022 | |
| Abbott Laboratories | $22.77 | 2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $20.68 | 2023 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $20.28 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.21 | 2021 | |
| Genzyme Corporation | $18.02 | 2023 | |
| Optos, INC. | $17.62 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lilly USA, LLC | $14.80 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.61 | 2021 | |
| Eisai INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Baumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.